167 related articles for article (PubMed ID: 8453721)
1. K-ras and p53 point mutations in 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced hamster lung tumors.
Oreffo VI; Lin HW; Padmanabhan R; Witschi H
Carcinogenesis; 1993 Mar; 14(3):451-5. PubMed ID: 8453721
[TBL] [Abstract][Full Text] [Related]
2. K-ras mutations in lung tumors from A/J and A/J x TSG-p53 F1 mice treated with 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and phenethyl isothiocyanate.
Matzinger SA; Crist KA; Stoner GD; Anderson MW; Pereira MA; Steele VE; Kelloff GJ; Lubet RA; You M
Carcinogenesis; 1995 Oct; 16(10):2487-92. PubMed ID: 7586156
[TBL] [Abstract][Full Text] [Related]
3. Dose-dependent ras mutation spectra in N-nitrosodiethylamine induced mouse liver tumors and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone induced mouse lung tumors.
Chen B; Liu L; Castonguay A; Maronpot RR; Anderson MW; You M
Carcinogenesis; 1993 Aug; 14(8):1603-8. PubMed ID: 8353844
[TBL] [Abstract][Full Text] [Related]
4. Mutational analysis of a dominant oncogene (c-Ki-ras-2) and a tumor suppressor gene (p53) in hamster lung tumorigenesis.
Oreffo VI; Lin HW; Gumerlock PH; Kraegel SA; Witschi H
Mol Carcinog; 1992; 6(3):199-202. PubMed ID: 1445620
[TBL] [Abstract][Full Text] [Related]
5. G to A transitions and G to T transversions in codon 12 of the Ki-ras oncogene isolated from mouse lung tumors induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and related DNA methylating and pyridyloxobutylating agents.
Ronai ZA; Gradia S; Peterson LA; Hecht SS
Carcinogenesis; 1993 Nov; 14(11):2419-22. PubMed ID: 7902220
[TBL] [Abstract][Full Text] [Related]
6. Effects of K-ras gene mutations in the development of lung lesions induced by 4-(N-methyl-n-nitrosamino)-1-(3-pyridyl)-1-butanone in A/J mice.
Kawano R; Takeshima Y; Inai K
Jpn J Cancer Res; 1996 Jan; 87(1):44-50. PubMed ID: 8609047
[TBL] [Abstract][Full Text] [Related]
7. Ki-ras mutations in 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-initiated and butylated hydroxytoluene-promoted lung tumors in A/J mice.
Matzinger SA; Gunning WT; You M; Castonguay A
Mol Carcinog; 1994 Sep; 11(1):42-8. PubMed ID: 7916989
[TBL] [Abstract][Full Text] [Related]
8. Comparative carcinogenicity and metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and N'-nitrosonornicotine in Syrian golden hamsters.
Hoffmann D; Castonguay A; Rivenson A; Hecht SS
Cancer Res; 1981 Jun; 41(6):2386-93. PubMed ID: 7237437
[TBL] [Abstract][Full Text] [Related]
9. Transformation of hamster pancreatic duct cells by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), in vitro.
Baskaran K; Laconi S; Reddy MK
Carcinogenesis; 1994 Nov; 15(11):2461-6. PubMed ID: 7955092
[TBL] [Abstract][Full Text] [Related]
10. Comparison of pulmonary O6-methylguanine DNA adduct levels and Ki-ras activation in lung tumors from resistant and susceptible mouse strains.
Devereux TR; Belinsky SA; Maronpot RR; White CM; Hegi ME; Patel AC; Foley JF; Greenwell A; Anderson MW
Mol Carcinog; 1993; 8(3):177-85. PubMed ID: 8216736
[TBL] [Abstract][Full Text] [Related]
11. Role of ras protooncogene activation in the formation of spontaneous and nitrosamine-induced lung tumors in the resistant C3H mouse.
Devereux TR; Anderson MW; Belinsky SA
Carcinogenesis; 1991 Feb; 12(2):299-303. PubMed ID: 1995195
[TBL] [Abstract][Full Text] [Related]
12. Nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced pulmonary adenocarcinomas in Syrian golden hamsters contain beta 2-adrenergic receptor single-nucleotide polymorphisms.
Masi T; Cekanova M; Walker K; Bernert H; Majidi M; Becker JM; Schuller HM
Genes Chromosomes Cancer; 2005 Oct; 44(2):212-7. PubMed ID: 15942941
[TBL] [Abstract][Full Text] [Related]
13. Role of the alveolar type II cell in the development and progression of pulmonary tumors induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in the A/J mouse.
Belinsky SA; Devereux TR; Foley JF; Maronpot RR; Anderson MW
Cancer Res; 1992 Jun; 52(11):3164-73. PubMed ID: 1591728
[TBL] [Abstract][Full Text] [Related]
14. Relationship between the formation of promutagenic adducts and the activation of the K-ras protooncogene in lung tumors from A/J mice treated with nitrosamines.
Belinsky SA; Devereux TR; Maronpot RR; Stoner GD; Anderson MW
Cancer Res; 1989 Oct; 49(19):5305-11. PubMed ID: 2670201
[TBL] [Abstract][Full Text] [Related]
15. Alterations in the K-ras and p53 genes in rat lung tumors.
Belinsky SA; Swafford DS; Finch GL; Mitchell CE; Kelly G; Hahn FF; Anderson MW; Nikula KJ
Environ Health Perspect; 1997 Jun; 105 Suppl 4(Suppl 4):901-6. PubMed ID: 9255578
[TBL] [Abstract][Full Text] [Related]
16. Histochemical characterization of non-neuroendocrine tumors and neuroendocrine cell hyperplasia induced in hamster lung by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone with or without hyperoxia.
Sunday ME; Willett CG; Graham SA; Oreffo VI; Linnoila RI; Witschi H
Am J Pathol; 1995 Sep; 147(3):740-52. PubMed ID: 7677185
[TBL] [Abstract][Full Text] [Related]
17. p53 mutations in head and neck squamous cell carcinomas from Sudanese snuff (toombak) users.
Lazarus P; Idris AM; Kim J; Calcagnotto A; Hoffmann D
Cancer Detect Prev; 1996; 20(4):270-8. PubMed ID: 8818386
[TBL] [Abstract][Full Text] [Related]
18. Pathobiology of lung tumors induced in hamsters by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and the modulating effect of hyperoxia.
Schuller HM; Witschi HP; Nylen E; Joshi PA; Correa E; Becker KL
Cancer Res; 1990 Mar; 50(6):1960-5. PubMed ID: 2306745
[TBL] [Abstract][Full Text] [Related]
19. Frequent mutations of Ki-ras but no mutations of Ha-ras and p53 in lung lesions induced by N-nitrosobis(2-hydroxypropyl)amine in rats.
Kitada H; Tsutsumi M; Tsujiuchi T; Takahama M; Fukuda T; Narita N; Konsihi Y
Mol Carcinog; 1996 Apr; 15(4):276-83. PubMed ID: 8634086
[TBL] [Abstract][Full Text] [Related]
20. p53 and Ha-ras mutations in chemically induced hamster buccal pouch carcinomas.
Chang KW; Lin SC; Koos S; Pather K; Solt D
Carcinogenesis; 1996 Mar; 17(3):595-600. PubMed ID: 8631150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
